Research News and Research

RSS

NanoViricides' President delivers speech at ASNM Second Annual Conference

NanoViricides, Inc. announced today that the Company President was invited to and presented a talk at the Second Annual Conference of the American Society for NanoMedicine (ASNM).

18 Oct 2010

EC grants orphan drug designation to S*BIO's SB1518 for treatment of myelofibrosis

S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.

18 Oct 2010

Emollient creams on eczemous skin likely to make condition worse

New research at the University of Bath suggests that using emollient creams to relieve the symptoms of eczema could actually make the condition worse.

18 Oct 2010

Possibilities of genetics research, personalized medicine, and behavioral intervention

Personalized medicine - improving the fit between patient and treatment - has become a major focus of research in fields from cancer treatment to the psychopharmacology of mental disorders. Genetic studies have suggested that an individual's genetic makeup renders him either more or less sensitive to stressful social environments - but can an individual's unique genotype also determine the effectiveness of preventative or therapeutic behavioral interventions?

18 Oct 2010

First Edition: October 18, 2010

Today's news includes continuing coverage of the run-up to the mid-term elections and how health reform is playing in the discourse.

18 Oct 2010

Women with normal bone mineral density at age 67 don't need osteoporosis screening again for 10 years

Since 2002, the U.S. Preventive Services Task Force has recommended that women ages 65 and older be routinely screened for osteoporosis and has suggested that a 2-year screening interval might be appropriate. However, what length the screening interval should be is a topic that remains controversial and undecided, with no definitive scientific evidence to provide guidance.

18 Oct 2010

MSF calls for donor countries to improve food aid nutrition standards on eve of World Food Day

Medecins Sans Frontieres (MSF) released a statement in advance of Saturday's World Food Day saying that the "world's biggest donors of food aid ... continued to supply and fund nutritionally 'substandard' food to developing countries, despite scientific evidence showing it was of little value in reducing child malnutrition," Reuters AlertNet reports.

18 Oct 2010

New emergency care guidelines simplify CPR

New emergency care guidelines simplify performing cardiopulmonary resuscitation (CPR) and highlight the need for high quality CPR by addressing some of the barriers to performing CPR. The Heart and Stroke Foundation of Canada, co-author of the 2010 Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC), released the guidelines today.

18 Oct 2010

IASP sponsors campaign for acute pain management

The Global Year Against Acute Pain launches today, focusing attention on a widely under-assessed and undertreated pain that affects most people throughout their lives. Sponsored by the International Association for the Study of Pain (IASP), the 12-month campaign focuses on education for health care professional and government leaders as well as public awareness to help lessen the gap between existing knowledge and technology for acute pain control and current pain management practice.

18 Oct 2010

Deductible-free screening encourages use of preventive care services

When they do not have to pay a health insurance deductible, people are more likely to undergo screening for conditions like cancer and high cholesterol. However, the increase is modest, and in high-deductible plans, it is quite small, according to a new study in the journal Health Services Research.

18 Oct 2010

Alcon concludes 'proof of concept' clinical trial of NovaBay's Aganocide for viral conjunctivitis treatment

NovaBay Pharmaceuticals, Inc. announced today that its development partner, Alcon Research, Ltd., has concluded its proof of concept clinical trial of NovaBay's patented lead Aganocide compound, NVC-422 for the treatment of viral conjunctivitis a highly contagious eye infection for which there are currently no marketed products.

18 Oct 2010

African-American children have higher risk of hypertension

Persistently high blood pressure, or hypertension, may spell worse heart trouble for black children under the age of 13 than for other children of the same ages, according to research led by scientists at Johns Hopkins Children's Center and published in the November issue of Pediatrics.

18 Oct 2010

Bend Research extends 3-year agreement with Bristol-Myers Squibb

Bend Research Inc. a leading independent technology-based drug-formulation development and manufacturing organization, announced today it has extended its drug discovery enablement and development services agreement with Bristol-Myers Squibb Company, a global biopharmaceutical company.

18 Oct 2010

OSU's Personalized Health Care National Conference focuses on P4 Medicine

Healthcare consumers took center stage at today's annual Ohio State University Medical Center Personalized Health Care National Conference. Speakers focused on ways that P4 Medicine – which is predictive, preventive, personalized and participatory – can revolutionize healthcare by engaging and empowering patients.

18 Oct 2010

UK College of Medicine celebrates 50th anniversary

The year 2010 marks a significant date in the history of the University of Kentucky College of Medicine as it celebrates its 50th anniversary. The festivities culminate on Oct. 15 with the Signature Event, held at the Keeneland Sales Pavilion. This year commemorates individuals who have been a part of the accomplishments of the past five decades and for those who will be a part of its bright future.

18 Oct 2010

Researchers to develop technologies that can mask horrid taste of children's medicines

A spoonful of sugar is the traditional way to help medicines 'go down'. But getting young children to take foul-tasting medicines - even if their lives depend on it - requires more than a bit of added sweetener. According to the World Health Organisation (WHO), each year over eight million children die of diseases that could be avoided if essential medicines were available in appropriate formulations for children.

18 Oct 2010

One in four applicants to U.S military are rejected for being overweight or obese

At a time when American military forces are stretched thin overseas, a growing number of potential recruits are too fat to enlist, according to an analysis by Cornell University researchers.

18 Oct 2010

UCSF professor receives National Medal of Science

UCSF Nobel laureate Stanley B. Prusiner, MD, UCSF professor of neurology and director of the Institute for Neurodegenerative Diseases, today (Oct. 15, 2010) was named to receive the National Medal of Science, the nation's highest honor for science and technology.

18 Oct 2010

Preliminary Phase 2 data of TZP-102 for diabetic gastroparesis to be presented at ACG annual meeting

Tranzyme Pharma announced today that John Wo, MD, Professor of Medicine and Director, Clinical Research, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, Louisville, KY, will present preliminary TZP-102 Phase 2 data at this year's ACG annual meeting. The event is being held at the Henry B. Gonzalez Convention Center in San Antonio TX, October 15-20, 2010. Professor Wo is scheduled to speak on Wednesday, October 20th at 8:50am in Ballroom C1.

18 Oct 2010

New imaging technique to study response of white blood cells to inflammation

Researchers at the University of Calgary Faculty of Medicine are using an innovative new imaging technique to study how white blood cells (called neutrophils) respond to inflammation, and have revealed new targets to inhibit the response.

18 Oct 2010

Research News and Research

NanoViricides' President delivers speech at ASNM Second Annual Conference

EC grants orphan drug designation to S*BIO's SB1518 for treatment of myelofibrosis

Emollient creams on eczemous skin likely to make condition worse

Possibilities of genetics research, personalized medicine, and behavioral intervention

First Edition: October 18, 2010

Women with normal bone mineral density at age 67 don't need osteoporosis screening again for 10 years

MSF calls for donor countries to improve food aid nutrition standards on eve of World Food Day

New emergency care guidelines simplify CPR

IASP sponsors campaign for acute pain management

Deductible-free screening encourages use of preventive care services

Alcon concludes 'proof of concept' clinical trial of NovaBay's Aganocide for viral conjunctivitis treatment

African-American children have higher risk of hypertension

Bend Research extends 3-year agreement with Bristol-Myers Squibb

OSU's Personalized Health Care National Conference focuses on P4 Medicine

UK College of Medicine celebrates 50th anniversary

Researchers to develop technologies that can mask horrid taste of children's medicines

One in four applicants to U.S military are rejected for being overweight or obese

UCSF professor receives National Medal of Science

Preliminary Phase 2 data of TZP-102 for diabetic gastroparesis to be presented at ACG annual meeting

New imaging technique to study response of white blood cells to inflammation

A new way of characterising biomolecules eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News